logo
Solace in strangers & knowing one is not alone: Rise of support circles

Solace in strangers & knowing one is not alone: Rise of support circles

Time of Indiaa day ago
My mind goes from 0 to 100 in a few seconds, said someone in the circle. "Mine goes from 0 to 1,000!" another reacted. Everyone laughed.
In a session where a group of anxious strangers had gathered in a room to share, the laughter was just the relaxing stimulus that we 'overthinkers' needed to poke a bit of fun at ourselves.
This writer — at her first such support circle meetup at a venue in Gurgaon — realised she was not alone. There was a whole tribe of overthinkers out there, struggling to live because of the anxiety-inducing situations their imaginations create. And here, they found each other.
"My mother has been a little unwell. I quit my job and moved cities to live with her. My mind just goes to the extreme and I act on my first instinct," a fellow participant shared.
You Can Also Check:
Gurgaon AQI
|
Weather in Gurgaon
|
Bank Holidays in Gurgaon
|
Public Holidays in Gurgaon
An advertising professional at the session sounded relatable when he said: "If everything is going well in my life and I'm happy, I start thinking about all the worst-case scenarios, everything that could potentially go wrong. It's like a calculation in my head so that I can prepare myself for the worst. I always need to have a plan B."
A copywriter said, "Even if I'm doing great at work, if I don't get praise from my boss or the best performance award, I assume that it's time to start looking for a new job."
"I fear I will never be able to find my purpose in life," said a software engineer, "I keep trying the next exciting thing and then quit in the middle, for fear of failing."
It's so tiring, the constant mental grind, the mind working its way through imagined scenarios at warp speed (while the world wonders why I space out so often). But the burden lifts when you know you're not alone. I came out feeling 10 kilos lighter.
Group therapy, not really
With increased awareness and more conversations about mental health since the Covid-19 pandemic, Delhi-NCR has seen a number of support circles come up in the last couple of years, attended by many in the 20-40 age group.
A small group of people meet and talk about what they're feeling. All sessions are moderated by a psychologist. Hosts make clear, however, that these are not a replacement for therapy, but a support to it. There are many things that bring strangers together — ranging from relationships and loneliness to overthinking, grief and sexual orientation.
A 25-year-old media professional from Surat said it took him a long time to come out to his parents.
When he finally did, they did not take it well. He arrived in Delhi last year and the support circle he found became his "second family". "I have met so many people like me. We all have similar stories — troubled relationships with our families, moving away from home, feeling lonely... all of this unites us," he said.
A 28-year-old lawyer living in Gurgaon had the rug pulled out from under her as her five-year-long relationship ended without warning.
Gradually, she also felt her friends pulling away as all she could talk about was her breakup. In support circles, however, she found comfort and empathy.
Spaces to share
One such circle is 'Stories of Hope' run by Ravnita Singh. The group meets once a month and the organisers keep it to 10 or fewer members.
The circle usually begins with people introducing themselves and sharing their reason for joining. Group activities are organised to make participants comfortable, so they can open up to each other.
"The idea behind this support circle is to give people an arena where they can feel OK sharing anything, especially things that bother them. We have tried to create a non-judgmental space where everyone feels welcome," said Singh.
When she founded Stories of Hope, Singh said, she expected all the participants would be women. To the surprise of the organisers, however, their first session saw only men turn up. "We realised they found it easier to share their feelings with people who didn't know them," Singh said.
Support Circle Delhi-NCR is another community that organises meetups every weekend. Each one has a theme and anyone who relates can join in. Like Singh, its founder Vishal Bisht said his own mental health journey had prompted him to start the sessions.
"It struck me that there must be so many people out there who could be going through something similar. There was no platform where people could just come and talk about their feelings.
So, I thought I should start one, because there are many like me who need someone to reach out to," said Bisht.
At the end of each meetup, Bisht and his team take feedback from participants about the psychologist. "Every psychologist has a different way of working, so we want people to let us know what method worked for them," he added.
Harsheen Vora, founder of Belong, said, "We are here to bring support groups to the country in a way that's here to stay."
Belong functions with the philosophy that conversations about mental health need not be sombre and serious. People attending their sessions can expect group hugs, cheers and fun postcards.
Not for everyone
Not everybody who attends these meetups, however, ends up enjoying them. One of the participants told TOI that she could not stop crying afterwards. "I thought I was unburdening myself but the whole experience made me feel like I had shared too much about my life and myself with complete strangers.
I immediately felt too vulnerable," she said.
Dr Sneha Sharma, consultant psychiatrist at Anvaya Healthcare, said it was essential to apply filters before letting people be part of a group, and an induction process should take place. "In case a person has an acute mental health disorder, we do not recommend they join a support circle because it could trigger them. Only if we think an individual will benefit from conversations there will we encourage them," she said.
Vora said if they felt someone was not comfortable sharing, they would tell them to pick up a card to stop the conversation. "We also get wonderful, sensitive souls who are able to gauge from people's facial expressions that they are uneasy, and either get them a glass of water or offer them a hug."
If participants are open to suggestions, others share the mental health tools or advice that worked for them. In case someone is triggered by the session, the psychologist speaks to them to make sure they have the resources to cope. "Our team always checks in with people after the session," Vora said, "We want to make sure everyone leaving the group is leaving lighter."
Stay updated with the latest local news from your
city
on
Times of India
(TOI). Check upcoming
bank holidays
,
public holidays
, and current
gold rates
and
silver prices
in your area.
Get the latest lifestyle updates on Times of India, along with
Raksha Bandhan wishes
,
messages
and
quotes
!
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tom Holland admits putting on his Spider-Man suit 'feels different this time', Entertainment News
Tom Holland admits putting on his Spider-Man suit 'feels different this time', Entertainment News

AsiaOne

time11 minutes ago

  • AsiaOne

Tom Holland admits putting on his Spider-Man suit 'feels different this time', Entertainment News

Tom Holland has admitted putting on his Spider-Man suit "feels different this time". The 29-year-old actor is set to appear in his fourth Spider-Man movie — Spider-Man: Brand New Day — which started filming in Glasgow. Scotland earlier this month and Tom has confessed he's feeling really positive about the shoot so far. In a video posted on social media, he explained: "I feel good, man. It's day one, my fourth ever day one on Spider-Man. "You know, it's funny, putting the suit on, it feels different this time, somehow. It's also the first time we've ever had fans on set for day one, so it's really exciting to share this with them." He added: "We've got some familiar faces on set. I'm just gonna do my best, hopefully get it right. No pressure." The movie star previously explained he was looking forward to being able to shoot the new movie on location because the previous instalment was mostly filmed on sound stages because of the Covid-19 pandemic. He told Flip Your Wig: "I'm obviously over the moon and so excited. Playing Spider-Man is like hanging out with an old pal, and I think we were really restricted with what we could do in the last movie because of Covid. "We shot the entire film on stages. Now we're really gonna lean into that old school filmmaking and shoot in real locations, which is why we're starting in Glasgow. We are gonna use the streets of Glasgow for this massive set piece that we are putting together ... "It's gonna feel like making [Homecoming] again. It's been such a long time that I've done it that it's gonna feel like a breath of fresh air. I think the fans are going to be over the moon with what we're putting together." [[nid:720776]]

Heart and kidney diseases, cancer: What else can GLP-1 drugs treat in addition to obesity?
Heart and kidney diseases, cancer: What else can GLP-1 drugs treat in addition to obesity?

Scroll.in

time42 minutes ago

  • Scroll.in

Heart and kidney diseases, cancer: What else can GLP-1 drugs treat in addition to obesity?

Research into the sugar-lowering powers of incretin hormones led to the discovery of GLP-1 drugs [like Ozempic and Mounjaro]. The added bonus of weight loss was serendipity. There seem to be many happy side effects of GLP-1 drugs. Of course, many of them are not because of the drugs themselves but because of weight loss. When you lose weight – whether through diet and exercise, bariatric surgery, or GLP-1 drugs – your knee pain and inflammation will reduce, heart health will improve, and so on. Yet it seems that GLP-1 drugs are directly improving health outcomes as well, apart from the benefits that accrue by reducing blood sugar and hunger. Dr Daniel Drucker, one of the scientists who discovered the GLP1 hormone, conducted an experiment on mice with systemic inflammation. When treated with GLP-1 drugs, the inflammation decreased. However, if the drug was blocked from reaching the brain, the inflammation did not reduce. This suggests that the brain plays a critical role in inflammation, and that reducing it may be directly mediated through the brain and not just indirectly due to weight loss. GLP-1 receptors – the switches activated by the drug – are found in the heart, liver, kidneys, pancreas, stomach, intestines and brain. As with many hormones, GLP-1's effects may not be limited to hunger and satiety alone but may also have multiple other functions. The full range of benefits these drugs can have in treating various diseases is still being discovered. In October 2018, Novo Nordisk, the company that holds the patent for semaglutide, began a trial to study the impact of the drug on the cardiovascular health of people who had heart disease and were overweight or obese but did not have diabetes. They enrolled over 17,000 people from diverse backgrounds. Their mean BMI was 33, and nobody was less than BMI 27. They were divided into two similar groups. One was given semaglutide (Wegovy) and the other was given a placebo. As the trial progressed, Covid-19 struck. Both groups saw similar rates of infection. Among the 184 who died of Covid-19, 78 had been taking semaglutide and 106 were on placebo. The difference is significant enough to suggest that the drug helped save some lives. In the trial, some died of reasons other than the pandemic. After accounting for all causes of death, those taking the drug saw 19 per cent fewer fatalities. No, this does not mean that GLP-1 drugs can be a treatment for Covid-19. What it does show is that the drug is improving overall health through weight loss and reduced inflammation. It confirms what we know about obesity: It's a disease. Did some of those patients survive the pandemic only because weight loss improved their overall health, or also because the drug reduced their inflammation levels, or were there more reasons? This is an open question because scientists are still discovering the full range of what GLP-1 drugs do inside the body. Their action on various diseases could help understand the disease better, perhaps aiding the discovery of new specific drugs and treatments for those diseases. GLP-1 drugs themselves could, some day, be prescribed for many of those conditions. It is important to note that research is ongoing and incomplete. Patients should not self-medicate. Even if GLP-1 drugs are approved by the US FDA or other regulators for some of these conditions, they must be used only under medical supervision. Here are some medical conditions in which GLP-1 drugs have been found to be helpful so far. Heart disease In March 2024, the US FDA approved Wegovy (semaglutide, same as Ozempic) for patients who had heart disease along with obesity or were overweight even if they did not have diabetes. This followed a large trial called SELECT (the same trial that showed the Covid-19 effect fortuitously), which had 17,600 patients enrolled in two groups. In the placebo group, 8 per cent of participants saw major adverse cardiovascular events (MACEs), such as heart attack, stroke or cardiovascular death. In the group taking semaglutide, the incidence was 6.5 per cent. That's a nearly 20 per cent reduction in risk. While this trial used weekly injectable semaglutide, the more recent SOUL trial, involving almost 10,000 participants, used oral semaglutide (Rybelsus) and showed a reduction in MACE of 14 per cent. Statins remain the main drug for people with heart disease, but these results demonstrate the role of semaglutide in the prevention of heart disease on top of statin therapy. Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine countries, including the US, called the SUMMIT trial, participants with heart failure taking tirzepatide for two years had significantly improved cardiovascular health and reduced progression of heart failure. An analysis of 13 GLP-1 drug trials comprising more than 80,000 patients showed significant reductions in MACE, overall and cardiovascular mortality, stroke, and need for coronary procedures like angioplasty and surgery, regardless of the presence of diabetes. The benefits could not be explained by weight loss alone. These trials have led to guidelines that all people with diabetes and/or obesity who either suffer from or are at risk of heart disease should be treated with GLP-1 drugs. However, since people with diabetes and/or obesity are at higher risk of heart attack and stroke anyway, it is prudent to consider the prescription of these drugs in most people with diabetes even if they have no evidence of heart disease. Chronic kidney disease In January 2025, the US FDA approved the use of semaglutide in patients who have both diabetes and kidney disease. Our kidneys filter out toxins from the body and pass them through the urine. Their ability to do so starts declining in patients with diabetes. The FLOW trial showed that for patients with both type 2 diabetes and chronic kidney disease, taking semaglutide lowered the risk of complications (dialysis, need for transplant) by 24 per cent. It also slowed down the decline of their kidney function. Moreover, in a post hoc analysis of the SURPASS-4 randomised clinical trial, tirzepatide decreased protein excretion, slowed decline in kidney function and reduced death due to kidney causes in patients with type 2 diabetes. Cancer Since obesity raises the risk of some types of cancer, it is not surprising that studies have started finding a reduced incidence of cancer among those taking GLP-1 drugs. This is similar to the reduced risk of cancer seen among those who have undergone bariatric surgery. Obesity-related cancers are concentrated around the metabolic organs and, among women, around the reproductive organs as well. An observational study of 1.65 million patients in the US found a reduced risk of ten types of obesity-related cancers among diabetes patients taking GLP-1 drugs as compared to those on insulin. Another study found the risk of 13 types of cancer reduced by 22 per cent in those who underwent bariatric surgery and by 39 per cent among those who took GLP-1 drugs. Excerpted with permission from The Weight Loss Revolution, Ambrish Mithal and Shivam Vij, Juggernaut.

Nearly 100,000 Malaysians renounce citizenship for Singapore in a decade, says Home Ministry
Nearly 100,000 Malaysians renounce citizenship for Singapore in a decade, says Home Ministry

The Star

timean hour ago

  • The Star

Nearly 100,000 Malaysians renounce citizenship for Singapore in a decade, says Home Ministry

KUALA LUMPUR: A total of 97,318 Malaysians have renounced their citizenship to become citizens of Singapore between 2015 and June 2025, according to the Home Ministry. The figures were provided in a written reply to a question from Datuk Seri Takiyuddin Hassan (PN-Kota Bharu) at the Dewan Rakyat on Monday (Aug 11). In 2015, 7,394 Malaysians renounced their citizenship, followed by 8,654 in 2016, and 7,583 in 2017. The numbers remained steady with 7,665 in 2018, but saw a significant increase in 2019 with 13,362 individuals making the switch. The trend dipped in 2020 with 5,591 renunciations, likely influenced by the Covid-19 pandemic. However, numbers picked up again with 7,956 in 2021 and 5,623 in 2022. A substantial increase was recorded in 2023 with 11,500 Malaysians making the change. The highest number within this period was in 2024, with 16,930 renunciations, and as of June 30 this year, 6,060 Malaysians have opted for Singaporean citizenship. Over the past decade, Malaysia has reportedly grappled with a significant brain drain, where skilled professionals leave the country for opportunities abroad. This trend is driven by the pursuit of higher salaries, better career prospects, and improved quality of life in countries like Singapore, Australia, and the United States. The sectors most affected include healthcare, engineering, finance, and information technology.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store